BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ohr Pharmaceutical 

1245 Brickyard Road
Suite 590
Salt Lake City  Utah  84106  U.S.A.
Phone: 347-753-4389 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Ohr Pharmaceutical (OHRP) Added To The Russell Indexes 6/30/2014 7:39:25 AM
Vista Partners Updates Coverage On Ohr Pharmaceutical (OHRP) (NASDAQ: OHRP); Raises Price Target To $31 6/27/2014 10:46:24 AM
Ohr Pharmaceutical (OHRP) To Host Conference Call And Webcast To Discuss Squalamine Interim Phase 2 Data In Wet-AMD 6/24/2014 7:43:48 AM
Ohr Pharmaceutical (OHRP) Eye Drug Falls Short In Phase 2 Trial 6/24/2014 7:00:52 AM
Ohr Pharmaceutical (OHRP) Announces Closing Of SKS Ocular Acquisition; Strengthens Executive Management Team 6/2/2014 9:26:08 AM
Ohr Pharmaceutical (OHRP) Announces Agreement To Acquire Technology Assets Of SKS Ocular 5/16/2014 11:59:21 AM
Ohr Pharmaceutical (OHRP) Announces Initiation Of Investigator Sponsored Trial Of Squalamine Eye Drops In Diabetic Macular Edema 5/9/2014 9:47:56 AM
Ohr Pharmaceutical (OHRP) Announces Completion Of Enrollment In Phase 2 Clinical Trial Of Squalamine Eye Drops In Wet-AMD 4/29/2014 9:40:06 AM
Ohr Pharmaceutical (OHRP) Announces $18 Million Registered Direct Offering Of Common Stock 4/8/2014 7:27:26 AM
Ohr Pharmaceutical (OHRP) To Present At The 26th Annual ROTH Conference 3/10/2014 9:48:28 AM
1234567